World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update

Ben Freedman1, Gerhard Hindricks2, Amitava Banerjee3

  • 1Heart Research Institute, University of Sydney, Sydney, AU.

Global Heart
|July 2, 2021
PubMed

Insights

The World Heart Federation updated its Atrial Fibrillation (AF) Roadmap to address challenges in reducing global cardiovascular disease. The update emphasizes practical solutions and new technologies for AF management, especially in low-middle income countries.

Area of Science:

  • Cardiology
  • Public Health
  • Health Informatics

Background:

  • Cardiovascular disease poses a significant global health burden and escalating healthcare costs.
  • Atrial Fibrillation (AF) is a growing concern due to population aging and increased cardiovascular risk factors.
  • The World Heart Federation (WHF) initiated a Roadmap to guide interventions for major cardiovascular diseases.

Purpose of the Study:

  • To update the 2017 AF Roadmap, incorporating technological advancements and addressing persistent barriers to care.
  • To provide guidance on feasible priority interventions for AF management across diverse countries.
  • To identify strategies for overcoming roadblocks in AF prevention and treatment, particularly for low-middle income countries.

Main Methods:

  • Review of technological advancements since 2017, including AI, mHealth, and digital health solutions.
  • Assessment of progress on previously identified barriers and solutions for AF management.
  • Identification of priority areas for intervention, focusing on advocacy, education, and integrated healthcare access.

Main Results:

  • Significant technological progress in AF identification, prediction, and rhythm control methods.
  • Increased availability of non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention.
  • Persistent challenges and slow progress in implementing AF management strategies globally.

Conclusions:

  • The 2020 AF Roadmap update highlights the need for increased advocacy, improved physician education, and enhanced patient health literacy.
  • Novel approaches, including mHealth and digital transformations, are crucial for improving access to integrated AF care.
  • Implementing practical and innovative solutions is essential to reduce AF-related death and disability, especially in resource-limited settings.

Related Concept Videos

Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...